×
About 248,918 results

How to fit clothing into the circular economy.
https://doi.org/10.1038/d41586-022-03651-2
Nature Savage N

Nov 18th, 2022 - How to fit clothing into the circular economy.|2022|Savage N,|economics,supply & distribution,trends,economics,

Beware the false hope of recycling.
https://doi.org/10.1038/d41586-022-03645-0
Nature Syberg K

Nov 18th, 2022 - Beware the false hope of recycling.|2022|Syberg K,|economics,trends,economics,trends,

To beat Ebola in Uganda, fund what worked in Liberia.
https://doi.org/10.1038/d41586-022-03695-4
Nature Fallah MP

Nov 16th, 2022 - To beat Ebola in Uganda, fund what worked in Liberia.|2022|Fallah MP,|economics,prevention & control,statistics & numerical data,economics,epidemiology,prevention & control,epidemiology,epidemiology,

Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hyper...
https://doi.org/10.1161/JAHA.122.026620
Journal of the American Heart Association; Schikowski EM, Swabe G et. al.

Nov 13th, 2022 - Background Pharmacologic treatment for pulmonary arterial hypertension (PAH) improves exercise capacity, functional class, and hemodynamic indexes. However, monthly prescription costs often exceed $4000. We examined associations between (1) medication copayment and (2) annual household income with adherence to pulmonary vasodilator therapy among individuals with PAH. Methods and Results We used...

The scandal of researchers paid less than a living wage.
https://doi.org/10.1038/d41586-022-03472-3
Nature

Nov 4th, 2022 - The scandal of researchers paid less than a living wage.|2022||economics,economics,prevention & control,economics,

'Not even enough money for food': graduate students face cash crunch.
https://doi.org/10.1038/d41586-022-03478-x
Nature Woolston C

Nov 2nd, 2022 - 'Not even enough money for food': graduate students face cash crunch.|2022|Woolston C,|economics,economics,

Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613764
AIDS (London, England); Trickey A, Walker JG et. al.

Oct 29th, 2022 - Non-governmental organizations (NGOs) in Ukraine have provided HIV testing, treatment, and condom distribution for MSM. HIV prevalence among MSM in Ukraine is 5.6%. We estimated the impact and cost-effectiveness of MSM-targeted NGO activities in Ukraine. A mathematical model of HIV transmission among MSM was calibrated to data from Ukraine (2011-2018). The model, designed before the 2022 Russia...

Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Pa...
https://doi.org/10.1056/NEJMp2210198
The New England Journal of Medicine; Dhruva SS, Ramachandran R et. al.

Oct 28th, 2022 - Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Path Forward?|2022|Dhruva SS,Ramachandran R,Ross JS,|economics,therapeutic use,economics,statistics & numerical data,economics,statistics & numerical data,economics,statistics & numerical data,epidemiology,

The missing risks of climate change.
https://doi.org/10.1038/s41586-022-05243-6
Nature Rising J, Tedesco M et. al.

Oct 27th, 2022 - The risks of climate change are enormous, threatening the lives and livelihoods of millions to billions of people. The economic consequences of many of the complex risks associated with climate change cannot, however, currently be quantified. Here we argue that these unquantified, poorly understood and often deeply uncertain risks can and should be included in economic evaluations and decision-...

Association of Hospital Participation in Bundled Payments for Care Improvement Advanced...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597389
JAMA Shashikumar SA, Gulseren B et. al.

Oct 26th, 2022 - Bundled Payments for Care Improvement Advanced (BPCI-A) is a Centers for Medicare & Medicaid Services (CMS) initiative that aims to produce financial savings by incentivizing decreases in clinical spending. Incentives consist of financial bonuses from CMS to hospitals or penalties paid by hospitals to CMS. To investigate the association of hospital participation in BPCI-A with spending, and to ...

Federal Government Funds Center for Mental Health and Social Media.
https://doi.org/10.1001/jama.2022.15482
JAMA Suran M

Oct 26th, 2022 - Federal Government Funds Center for Mental Health and Social Media.|2022|Suran M,|economics,economics,economics,

Safety and efficacy of low-cost alternative urokinase in acute ischemic stroke: A syste...
https://doi.org/10.1016/j.jocn.2022.09.015
Journal of Clinical Neuroscience : Official Journal of Th... Kharel S, Nepal G et. al.

Oct 25th, 2022 - Use of intravenous thrombolysis (IVT) for treatment of acute ischemic stroke (AIS) varies greatly between countries, ranging from 10% to 15% in high-income countries to less than 2% in low- and middle income countries (LMICs). This is because alteplase is expensive and has been cited as one of the most common barriers to IVT in LMICs. Urokinase (UK) is a thrombolytic agent which is almost 50 ti...

Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579917
JAMA Dusetzina SB, Huskamp HA et. al.

Oct 19th, 2022 - Prescription drug spending is a topic of increased interest to the public and policymakers. However, prior assessments have been limited by focusing on retail spending (Part D-covered drugs), omitting clinician-administered (Part B-covered) drug spending, or focusing on all fee-for-service Medicare beneficiaries, regardless of their enrollment into prescription drug coverage. To estimate the pr...

Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAV...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575578
Circulation. Cardiovascular Interventions; Butala NM, Wood DA et. al.

Oct 19th, 2022 - The 3M-TAVR trial (3M-Transcatheter Aortic Valve Replacement) demonstrated the feasibility and safety of next-day hospital discharge after transfemoral TAVR with implementation of a minimalist pathway. However, the economic impact of this approach is unknown. Therefore, we evaluated costs for patients undergoing minimalist TAVR compared with conventional TAVR. We used propensity matching to com...

Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566473
International Journal of Environmental Research and Publi... Żelewski P, Wojna M et. al.

Oct 15th, 2022 - The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of ...

Do soaring energy costs mean we are using less?
https://doi.org/10.1038/d41586-022-03261-y
Nature Ledford H

Oct 15th, 2022 - Do soaring energy costs mean we are using less?|2022|Ledford H,|economics,economics,

Why I think ending article-processing charges will save open access.
https://doi.org/10.1038/d41586-022-03201-w
Nature Alperin JP

Oct 13th, 2022 - Why I think ending article-processing charges will save open access.|2022|Alperin JP,|economics,

Laggard rich countries risk slowing the fight against AIDS, malaria and TB.
https://doi.org/10.1038/d41586-022-03129-1
Nature

Oct 6th, 2022 - Laggard rich countries risk slowing the fight against AIDS, malaria and TB.|2022||epidemiology,prevention & control,economics,epidemiology,prevention & control,epidemiology,prevention & control,epidemiology,prevention & control,

Chronic Disease Burden and Financial Problems Are Intertwined.
https://doi.org/10.1001/jama.2022.15440
JAMA Slomski A

Oct 5th, 2022 - Chronic Disease Burden and Financial Problems Are Intertwined.|2022|Slomski A,|economics,economics,

Reward research for being useful - not just flashy.
https://doi.org/10.1038/d41586-022-03131-7
Nature Flagg M

Oct 5th, 2022 - Reward research for being useful - not just flashy.|2022|Flagg M,|economics,standards,